Exit Now! 3 Biotech Stocks to Sell in February 2024

The unpredictability of the biotech sector, highlights the inherent risks involved in certain biotech stocks to sell.2023 was a rough year for the market, marked by a 10% plunge in the SPDR S&P Biotech ETF (XBI), alongside widespread layoffs and fundraising challenges. Moreover, despite forecasts pointing to a potential rebound in 2024, the biotech industry is struggling to adapt post-pandemic. For many biotech firms, securing private funding and launching successful IPOs remains a daunting task.Furthermore ...